A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Actuate Therapeutics Inc.
Merck Sharp & Dohme LLC
City of Hope Medical Center
Merck Sharp & Dohme LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Gilead Sciences
M.D. Anderson Cancer Center
Japan Breast Cancer Research Group
Virginia Commonwealth University
City of Hope Medical Center
Dana-Farber Cancer Institute
University of Chicago
City of Hope Medical Center
University of California, San Francisco
Thomas Jefferson University
Thomas Jefferson University
NYU Langone Health
Orinove, Inc.
US Oncology Research
Fudan University
Fudan University
Fondazione Michelangelo
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University Hospital, Ghent
University of Nebraska
Rutgers, The State University of New Jersey
Infinity Pharmaceuticals, Inc.
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Spanish Breast Cancer Research Group
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
University of Colorado, Denver
US Oncology Research
Washington University School of Medicine
National Cancer Institute (NCI)
West China Hospital
University of Kansas Medical Center
Taizhou EOC Pharma Co., Ltd.
ChineseAMS
ChineseAMS
Memorial Sloan Kettering Cancer Center
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC